| 查看: 4373 | 回复: 10 | |||
[交流]
cancer research 投稿要求
|
|||
| 想请教一下，cancer research的投稿有什么要求吗？文章格式有什么要求吗？ |
回复此楼» 猜你喜欢
哎
已经有5人回复
-
院士建议：对勇于提出解决卡脖子问题新解决方案的学者加大资助力度
已经有10人回复
-
25申博记录贴
已经有4人回复
-
紫外光谱
已经有3人回复
-
事业单位还是大学好？
已经有16人回复
-
考研英语带学
已经有5人回复
-
298求调剂
已经有8人回复
-
家乡二本高校/沿海传统私企，如何抉择？
已经有13人回复
-
下雨了
已经有19人回复
-
小孩7岁，上一年级，不自信，学习较差
已经有30人回复
» 本主题相关价值贴推荐，对您同样有帮助:
- sci期刊最新变化！
已经有30人回复
- 投过Journal of Nanoparticle Research帮忙：此期刊对形成机理的解释有要求吗
已经有3人回复
- British Journal of Cancer投稿
已经有9人回复
- 主流材料类和纳米类期刊2013年影响因子预测！（2013.5.31已更新）
已经有216人回复
- African Journal of Microbiology Research老是要求我审稿，怎么办
已经有4人回复
- 2012版中国科技论文统计源期刊目录
已经有19人回复
- 求助生物、医学类1分左右的SCI投稿期刊选择（论文内容为癌症细胞的生物学研究）
已经有5人回复
- Research Highlights的格式需要怎么写才符合杂志要求
已经有9人回复
- 投稿Nano Research & J. Mater. Chem. ?
已经有19人回复
- 想投European Journal of Medicinal Chemistry，投稿要求怎么找啊？
已经有3人回复
- 【转载】A Postdoctoral Position in Hematological Cancer Research
已经有1人回复
- 关于 SCI 中 常见缩写的规则
已经有18人回复
- 【资源】英文论文写作、投稿详解———送给新手
已经有24人回复
- 给Nature投稿：一个失败的故事
已经有64人回复
» 抢金币啦！回帖就可以得到:
-
大湾区大学（筹）常建课题组与中国科学技术大学余彦教授联合招收新型锂电池方向博士后
+1/378
-
东北大学Derek Lovley教授团队招收博士生、推免研究生等
+1/130
-
恭喜老弟以第一作者发表三大顶刊文章！！！！
+1/95
-
齐鲁工业大学食品科学博士招聘
+1/82
-
北航工程热物理、航空工程与环境团队招聘博后
+1/42
-
燃料电池方向。合同一年开始，可更新。
+5/40
-
青岛科技大学材料学院 2024年 金属纳米团簇团队考研调剂招生【最后的机会啦】
+1/34
-
材料/化学上岸的最后机会了！合肥综合性国家科学中心能源研究院与安师大、安理工联培
+5/30
-
瑞典-招聘一名二维材料压力传感器方向博后
+1/16
-
请教各位合成MOF的大佬，DMF在MOF合成中的作用贡献
+1/15
-
恋爱脑男
+1/11
-
合肥综合性国家科学中心大健康研究院张珍课题组拟招收1名博士（申请审核，4月25日前）
+1/9
-
cyclohexyl alcohol为什么不是“cyclohexayl”alcohol? hexa为什么省略a
+1/7
-
郑州大学物理学院招聘实验助理
+1/5
-
实验室转让一台布鲁克 LUMOS II 红外光谱仪
+1/5
-
靠谱哥哥找对象，非诚勿扰
+1/4
-
香港科技大学 结构健康检测 / 结构工程 方向全奖招博士研究生 及 科研助理
+1/3
-
求大神
+1/3
-
300求调剂
+1/2
-
论文投稿，编辑都不送审
+1/1
+1/378
★ ★ ★
小木虫: 金币+0.5, 给个红包，谢谢回帖
看天: 金币+2, 鼓励一下 2012-11-20 21:10:49
小木虫: 金币+0.5, 给个红包，谢谢回帖
看天: 金币+2, 鼓励一下 2012-11-20 21:10:49
2楼2012-11-16 17:39:30
3楼2012-11-16 20:37:01
4楼2012-11-19 04:22:18
5楼2012-11-20 13:40:02
6楼2012-11-20 18:49:42
7楼2012-11-21 10:46:04
8楼2014-02-03 23:51:23
9楼2014-02-03 23:52:08
★
小木虫: 金币+0.5, 给个红包，谢谢回帖
小木虫: 金币+0.5, 给个红包，谢谢回帖
|
Cancer Research (CanRes): Instructions for Authors SmartSubmit Scope Cancer Research is the most frequently cited cancer journal in the world. The journal publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience spanning basic, preclinical, clinical, prevention, and epidemiologic research. Cancer Research seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer. The main scope of the journal is captured in its primary subsections, which focus on molecular and cellular pathobiology, tumor and stem cell biology, therapeutics and targets, microenvironment and immunology, prevention and epidemiology, and integrated systems and technology. Please note that the journal is unable to entertain pre-submission inquiries. See the Submission Procedures section of the Instructions for Authors for information on submitting a manuscript for consideration. Papers are stringently reviewed, and only those that report results of novel, timely, and broadly-significant research meeting high standards of scientific merit are accepted for publication. The following criteria provide an overview of the types of studies considered by the journal: Findings which have not been previously published in another tumor model. Studies performed in multiple cell lines. Conclusions which are not representative of incremental findings. Studies which include a clearly written title and abstract which communicate the study's impact of significance to non-experts. An incisive rationale that could interest a broad audience. Manuscripts containing in vivo data. Although in vivo data is not required, studies containing this data are preferred. A potentially generalizable, broad impact conclusion. Studies which describe RNA interference (RNAi) must contain one non-specific control and two specific siRNAs for each knockdown target of interest. Additional data showing that knockdown at the level of protein expression (not just mRNA) was achieved is required. Categories of Publication Top The following types of articles will be considered for publication. Note that word counts are exclusive of references. Authors are advised that submissions not adhering to the guidelines provided below, including word counts, may be returned unreviewed. Research Articles Original studies offering broad impact across the fields of basic, preclinical, clinical, prevention and epidemiologic cancer research. The reports should be well-documented, novel, and significant to the field as a whole. The Editor-in-Chief and members of the senior editorial board reserve the right to edit title, abstract, and précis for articles that are accepted to improve their clarity, brevity, and quality. 250-word abstract 5,000 words of text 7 tables and/or figures (Please keep the number of panels per figure to an absolute minimum) 50 references Priority Reports Short, definitive reports of findings of high impact, significance, and timeliness. These reports receive an accelerated review. Papers submitted as Priority Reports should include a section for Materials and Methods as well as Results and Discussion (Results and Discussion may be combined but Materials and Methods may not be combined with any other section). The Editor-in-Chief and members of the senior editorial board reserve the right to edit title, abstract, and précis for articles that are accepted, to improve their clarity, brevity, and quality. 250-word abstract 2,500 words of text 4 tables and/or figures — Please note that each figure or table is limited to a maximum of 4 panels. 20 references Reviews Articles that review a timely subject important to cancer researchers. Reviews must be written as concisely as possible. Authors of unsolicited Review Articles must first submit an outline of the proposed article for consideration. The outline should be sent to the attention of Dr. Danny R. Welch, Deputy Editor for Reviews (Fax: (215) 440-9354; E-mail: cancerres@aacr.org). All Review Articles, whether invited or not, will be subject to peer review. The length restrictions for this category of publication are provided below. Longer reviews will be considered only at the discretion of the Deputy Editor for Reviews. 200-word abstract 2,000 words of text 1 original figure with a maximum of 4 panels 30 references Perspectives in Cancer Research Articles that present fresh insights on a very active or underdeveloped area of research, with a personal viewpoint on the area, its pressing issues, or its development. 200-word abstract 3,000 words of text 3 tables and/or figures, each with a maximum of 4 panels 30 references Public Issues Brief articles on topics of interest to cancer researchers and the general public. These topics might include articles on advocacy for funding cancer research, government relations, training in the field, public education, or science education. 2,000 words of text Letters to the Editor In the spirit of open scientific dialogue, the Editors invite the submission of correspondence that presents considered opinions in response to articles published in the journal. Letters to the Editor will be peer reviewed and, if found to meet the requisite publication criteria (scholarly commentary on a subject of importance and interest to the broad readership), the Letter may be sent to the author(s) of the originally published article and possibly to other interested parties for a response to be published in the same issue of the journal as the Letter. Please note that the journal will not consider Letters to the Editor regarding Cancer Research articles that were published more than 3 months prior. Correspondence concerning articles that have not been published in Cancer Research will not be considered. The length restrictions for this category of publication are as follows: 400 words of text 5 references, the first of which must be the citation for the original article under discussion Letters may contain figures or tables only if they show data that refute the conclusions of the originating article. Figures or tables showing unpublished data in support of the conclusions of the originating article will not be considered. Include a title: "Running title of the original article" — Letter Meeting Reports Brief reports of symposia and conferences in cancer research. Reports must be submitted within 2 months of the meeting date in order to maintain their timeliness. Only those Meeting Reports dealing with topics of interest to the readership that contain novel information and insights from the meeting will be accepted for publication. A Meeting Report should offer a thoughtful, critical commentary that shows an appreciation of the connections among various presentations and reveals the consensus, if any, that emerged on matters of importance at the meeting. Before submitting a Meeting Report for consideration, potential authors must send a letter to the attention of Dr. Mariano Barbacid, Deputy Editor for Meeting Reports, to inquire whether the suggested meeting satisfies criteria for consideration. Letters of inquiry should be sent to the Publications Office (Fax: (215) 440-9354; E-mail: cancerres@aacr.org). Length restrictions for this category of publication are as follows: 100 word abstract 2,500 words of text Figures and/or tables are not permitted without prior approval from the Editors References, if necessary, must be kept to a minimum A statement of the purpose of the meeting, an integrated summary of the findings presented, and recommendations for future research The names and affiliations of key speakers should be given in an appendix that is submitted as supplemental information, not as part of the manuscript text Mathematical Oncology Research Articles Published in the Integrated Systems and Technologies section of the journal, Mathematical Oncology articles include mathematical approaches to problems in cancer research. These articles will contain new testable hypotheses, integration of theory and experimental data, facilitation of wide-ranging investigations, and basic laws of biology. The format and length restrictions for this category of publication are as follows: Title: 150 characters (not including spaces) Abstract: 350 words, in the following construction: Summarize the background, cancer significance, and question "set the stage"  Describe the findings ("deliver the result" Summarize the meaning and implication of the advance ("place in context" Succinct nonmathematical description of the major results; please use the subheading Major Findings to differentiate this portion of the abstract Quick Guide to Equations and Assumptions: Up to 5 equations, 800 words maximum Present key equations; for each, include a description and/or definition of the components of the equation Present all major assumptions of the model Body Text: 5,000 text words Figures and/or Tables: maximum of 7. Authors are asked to keep the number of panels per figure to an absolute minimum. Acceptable formats: TIFF, EPS, PPT Submit figures and tables as separate files References: 50 Supplementary Material: Submit the details of the computational procedures and a flowchart of the algorithm(s) as Supplementary Material. Cancer Research encourages that all programs used in the calculations or detailed instructions to replicate the major findings also be provided as Supplementary Material. Prior to depositing a program, you must ensure and attest that the posted version executes properly. Deposit data used for analysis (curve fitting, approximations, parameter estimation, etc.) as Supplementary Material. |
10楼2014-02-04 03:03:16
11楼2014-08-12 17:11:11
